cardiology
SEX-SHOCK Risk Score for Cardiogenic Shock Development in ACS
Predicts risk of developing cardiogenic shock in patients presenting with acute coronary syndrome (ACS). Validated in STEMI and NSTEMI populations to identify high-risk patients for early intensive monitoring.
References
- Pöss J et al. Development and validation of the SEX-SHOCK risk score to predict the development of cardiogenic shock in patients with ACS. JACC Cardiovascular Interventions. 2017;10(20):2084-2093.
- Ibanez B et al. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. Eur Heart J. 2018;39(2):119-177.
Related
Curated clinical cross-links plus same-class fallbacks.
Drugs
- Noradrenaline (Cardiogenic Shock / Vasopressor) · Vasopressor / Cardiogenic Shock
- Hydrocortisone (ICU — Stress Dosing) · Corticosteroid (ICU/Septic Shock)
- Alteplase (STEMI Thrombolysis) · Thrombolytic / STEMI
- Streptokinase (STEMI Thrombolysis) · Thrombolytic / STEMI
- Folinic Acid (Calcium Folinate / Leucovorin) · Antidote / Chemotherapy Support
- Vasopressin / Terlipressin · Vasopressin Analogue — Vasodilatory Shock / Variceal Bleeding
Pathways
- Acute Heart Failure · ESC 2021 Heart Failure Guidelines; NICE NG106
- NSTEMI / Unstable Angina · ESC 2020 NSTEMI Guidelines; NICE NG185
- New-Onset Atrial Fibrillation · ESC 2020 AF Guidelines; NICE NG196
- Hypertensive Emergency · ESC/ESH 2018 Hypertension Guidelines; NICE NG136
- Bradycardia Management · Resuscitation Council UK ABCDE; ESC 2021 Pacing Guidelines
- Ventricular Tachycardia / Fibrillation · Resuscitation Council UK ACLS; ESC 2022 Ventricular Arrhythmia Guidelines
Decision support only — verify against MDCalc, NICE, or your local guideline before clinical use.